EMJ | Elevating the quality of healthcare globally

This site is intended for healthcare professionals

Continue

Latest News

All News
Hepatology
12 Sep 2025

Immune Genes Driving MAFLD Progression and Diagnosis Revealed

Emerging evidence points to the role of CD4+ T cell subsets in fuelling MAFLD-related inflammation and fibrosis.
Neurology
12 Sep 2025

LSD-Based Treatment Achieves Rapid Anxiety Relief in Clinical Trial

Single-dose MM120 provides fast, lasting anxiety relief in generalised anxiety disorder, paving the way for new treatments.
Microbiology & Infectious Diseases
12 Sep 2025

Three-Month Clofazimine Regimen Fails to Shorten Tuberculosis Treatment

A 3-month clofazimine- and rifapentine-containing regimen for drug-susceptible TB failed to improve cure rates and caused more severe adverse events than standard therapy, according to the Clo-Fast trial.
Dermatology
12 Sep 2025

Combined Tofacitinib and UVB Therapy Shows Promise in Vitiligo

Ultraviolet B (UVB) phototherapy is the traditional non-pharmacological approach, promoting repigmentation by stimulating melanin production.

Latest Articles

Interactive Content

Dermatology
12 Sep 2025

The POSITIVE Phase IV Study: Interim 52-Week Results on Patient Well-Being With Tildrakizumab

Psoriatic disease extends beyond the skin, imposing a significant psychosocial burden, often leading to embarrassment, social withdrawal…
Respiratory
11 Sep 2025

Choosing an Inhaled Corticosteroid/ Inhaled Long-Acting β2-Agonist for Your Patients with Moderate Asthma

Asthma causes substantial morbidity and mortality worldwide.1 Steps 3 and 4 of the Global Initiative for Asthma (GINA) strategy recommend…
Oncology
10 Sep 2025

Avelumab 1L Maintenance in aUC: Insights from 5000+ Real-World Patients

Urothelial carcinoma (UC), a prevalent cancer affecting the urinary tract, often progresses to an advanced, terminal…
Respiratory
3 Sep 2025

Selecting the COPD Device Most Likely to Benefit Your Patients

A discussion with a COPD specialist to understand the importance of selecting the right inhalation device for each patient.
All Interactive Content

Latest Infographics

All Infographics
Hematology
3 Sep 2025

Update to European Treatment Guideline for Large B Cell Lymphomas

Neurology
31 Jul 2025

CANYON: The Largest Interventional Trial in Becker

Sevasemten is an investigational agent that is currently not approved for use by any regulatory authority in any territory…
Hematology
24 Jul 2025

Ranking Treatments for Lenalidomide-Refractory Multiple Myeloma post DRd

Multiple myeloma is the second most common haematological malignancy, with an increasing global incidence…
Hematology
24 Jul 2025

The Immunotherapy Landscape for Multiple Myeloma

Take a look at our latest haematology infographic, which explores the current immunotherapy treatment landscape for multiple myeloma…

Latest Podcasts

All Podcasts
Respiratory
11 Sep 2025

RCC: Recognition to Management

Refractory Chronic Cough (RCC) is more than just a lingering symptom; it’s a misunderstood condition that disrupts lives…
Sara Tolaney
Oncology
9 Sep 2025

Onc Now: Episode 25: From Trials to Treatment in Breast Cancer Care

Sara Tolaney shares insights on breast cancer care, including her research on CDK4/6 inhibitors and exploring ways to de-escalate treatment.
Hepatology
8 Sep 2025

Alcohol in Hepatology

Explore the dual challenge of alcohol use disorder and liver disease in this series with Stephanie Rutledge.
Neurology
5 Sep 2025

The Diagnostic Odyssey of Friedreich’s Ataxia

Friedreich’s ataxia (FA) is a rare genetic disease that can affect children and adults and cause progressive neurodegeneration, loss of…

Latest Videos & Webinars

All Videos & Webinars
Konstanze Döhner, President Elect, European Hematology Association (EHA); Department of Internal Medicine III, University Hospital of Ulm, Germany.
Hematology
12 Sep 2025

EHA Interview 2025: Konstanze Döhner

EMJ spoke with Konstanze Döhner, President Elect of the European Hematology Association, about her priorities for the future of haematology, challenges in research and patient care, and the vision behind the EHA2025 theme “Borderless Hematology”.
Martin Dreyling, Professor of Medicine and Head of the Lymphoma Programme, Ludwig Maximilian University, Germany; Scientific Program Committee Chair EHA2025 European Hematology Association (EHA)
Hematology
12 Sep 2025

EHA Interview 2025: Martin Dreyling

EMJ spoke with Martin Dreyling, Chair of the EHA2025 Scientific Program Committee, about his career journey, what attendees can expect from the upcoming congress, and the vision behind its programme.
Flagship Journal
11 Sep 2025

EMJ's Latest Autumn Journal

The 2025 edition of our flagship journal is out now – featuring all the latest insights you need to know across healthcare. From the…
We’ve noticed you’re accessing
from North/South America.